Metrics 2.0» Industry Insights» Healthcare/Pharma:

$22B US Generic Drugs Industry by the Numbers

With the new Democratic Congress promising to lower health care costs, generic drug makers take on brand-name rivals to level the playing field, reports AP. Here are some key metrics and stats on the generic drugs market: 

Continue reading... "$22B US Generic Drugs Industry by the Numbers" »

US Health Care Spending to Double to $4.1 Trillion by 2016 - 20 Cents of Every 5 Dollars Spent

U.S. health care costs are set to double over the next 10 years to $4.1 trillion annually, or 1 dollar of every 5 dollars spent, according to a study by Centers for Medicare & Medicaid Services, published today in the Web edition of the journal Health Affairs.

Continue reading... "US Health Care Spending to Double to $4.1 Trillion by 2016 - 20 Cents of Every 5 Dollars Spent" »

Global Pharmaceutical Sales Grew 5% to $386 billion; U.S. Share $196 billion

Global pharmaceuticals sales through retail pharmacies increased 5% to $386.23 billion in 13 key markets in the 12-month period from November 2005 through to November 2006, according to IMS Retail Drug Monitor. 

Continue reading... "Global Pharmaceutical Sales Grew 5% to $386 billion; U.S. Share $196 billion" »

US Spent $1.99 trillion on Health Care in 2005, with Lowest Growth Since 1999

The U.S. health care spending increased 6.9% in 2005 to $1.988 trillion, or $6,697 per person, compared to 7.2% growth in 2004 and the lowest growth rate since 1999, according to a latest comprehensive study on health care spending by Centers for Medicare and Medicaid Services.

Continue reading... "US Spent $1.99 trillion on Health Care in 2005, with Lowest Growth Since 1999" »

U.S. New Drug Approvals at 8 Year Low; R&D Spend Hits $40B

U.S. regulators approved 18 new drugs in 2006, close to an eight-year low, as the number of medicines recommended for sale in 2006 and 2005 dropped from the annual average of 26 drugs recorded in the previous six years, according to U.S. data. 

Continue reading... "U.S. New Drug Approvals at 8 Year Low; R&D Spend Hits $40B" »

$30B Market Value Lost on World's Biggest-selling Drug Replacement Failure at Pfizer

Lipitor, the world's biggest-selling drug at $12.2 billion last year, is one of six Pfizer products losing patent protection by 2011. Pfizer's (PFE) shares fell as much as 15%, wiping nearly $30 billion off the company's market value, after the world's biggest drugmaker ended development of its cholesterol pill torcetrapib designed to replace Lipitor when its patent expires.

Continue reading... "$30B Market Value Lost on World's Biggest-selling Drug Replacement Failure at Pfizer" »

Global Mortality Predictions: AIDS No.3 & Traffic Fatalities No.4 Leading Causes of Death by 2030

Within the next 25 years, AIDS is set to join heart disease and stroke as the top three causes of death worldwide, according to a new report in the Public Library of Science's Medicine journal. AIDS is currently ranked fourth behind heart disease, stroke, and respiratory infections. 

Continue reading... "Global Mortality Predictions: AIDS No.3 & Traffic Fatalities No.4 Leading Causes of Death by 2030" »

Retail Pharma Sales Grew 5% to Over $379 billion Annual Rate

IMS Health reported $379.29 billion in drug sales through retail pharmacies in 13 key markets in the 12-month period from August 2005 through to August 2006, a 5% growth from year ago.  

Sales in the top five European markets showed a 4% constant exchange growth. North America posted a 6% sales growth at $204.85 billion in sales in the 12 months to August. The key therapy growth area for North America was the cytostatics group with a 15% growth at constant exchange. Japan's overall growth at constant exchange was 2%, with $57.14 billion sales in the 12 months to August 2006. 

Continue reading... "Retail Pharma Sales Grew 5% to Over $379 billion Annual Rate" »

California Leads World in Biomedical with $62B in Revenue

California's biomedical industry is the second largest contributor to its high technology economy, second only to computer consulting and programming, according to a report by the California Healthcare Institute (CHI) and PricewaterhouseCoopers.

California biomedical industry accounted for $62 billion in revenue in the state last year. 

Continue reading... "California Leads World in Biomedical with $62B in Revenue" »

As $50B biotech industry marks its 30th anniversary, some stats, facts & metrics

The founding of Genentech in April 1976 is considered the birth of U.S. biotech industry. Revenues of U.S. biotech firms topped $50 billion last year, up almost 16%, double the 8% growth rate of the traditional drug makers ($600B global pharma sales in 2005). Here are Some revealing stats on the U.S Biotech industry:

Continue reading... "As $50B biotech industry marks its 30th anniversary, some stats, facts & metrics" »


  ABOUT    CONTACT Metrics 2.0 RSS Feeds RSS   Metrics 2.0 Widgets for your site or blog WIDGETS   ARCHIVES


Enter Email for Daily Feed Delivery:


Essential Business Books